A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the most tolerable and safe dose of ZD6474 (Zactima,
Vandetanib) when given with standard chemotherapy, radiation therapy and surgery in patients
with cancer of the esophagus